Strategies for developing design spaces for viral clearance by anion exchange chromatography during monoclonal antibody production

Citations Over Time

Abstract

The quality-by-design (QbD) regulatory initiative promotes the development of process design spaces describing the multidimensional effects and interactions of process variables on critical quality attributes of therapeutic products. However, because of the complex nature of production processes, strategies must be devised to provide for design space development with reasonable allocation of resources while maintaining highly dependable results. Here, we discuss strategies for the determination of design spaces for viral clearance by anion exchange chromatography (AEX) during purification of monoclonal antibodies. We developed a risk assessment for AEX using a formalized method and applying previous knowledge of the effects of certain variables and the mechanism of action for virus removal by this process. We then use design-of-experiments (DOE) concepts to perform a highly fractionated factorial experiment and show that varying many process parameters simultaneously over wide ranges does not affect the ability of the AEX process to remove endogenous retrovirus-like particles from CHO-cell derived feedstocks. Finally, we performed a full factorial design and observed that a high degree of viral clearance was obtained for three different model viruses when the most significant process parameters were varied over ranges relevant to typical manufacturing processes. These experiments indicate the robust nature of viral clearance by the AEX process as well as the design space where removal of viral impurities and contaminants can be assured. In addition, the concepts and methodology presented here provides a general approach for the development of design spaces to assure that quality of biotherapeutic products is maintained.

Related Papers

• → Quality by design case study: An integrated multivariate approach to drug product and process development(2009)210 cited
• → A quality by design study applied to an industrial pharmaceutical fluid bed granulation(2012)98 cited
• → Characterization of a Monoclonal Antibody Cell Culture Production Process Using a Quality by Design Approach(2010)57 cited
• → Design Space Approach for the Optimization of Green Fluidized Bed Granulation Process in the Granulation of a Poorly Water-Soluble Fenofibrate Using Design of Experiment(2022)8 cited
• → Application of Quality by Design Concepts in the Development of Fluidized Bed Granulation and Tableting Processes(2013)14 cited